Skip to content

Blog

Select Health Area/Condition/Disease
NAD+ and Cancer: Current Research on Supplementation Safety and Risk

NAD+ and Cancer: Current Research on Supplementation Safety and Risk

NAD+ and Cancer: Current Research on Supplementation Safety and Risk
Cancer

NAD+ and Cancer: Current Research on Supplementation Safety and Risk

As NAD+ supplementation grows in popularity, questions about cancer risk have emerged. This article breaks down the research, highlights misleading media claims, and delves into the nuanced science...

Read more
Microscopic view of nerve cells illustrating nicotinamide riboside (NR) research on chemotherapy-induced peripheral neuropathy.
Cancer

Nicotinamide Riboside Helps Protect Nerve Fibers During Chemotherapy and Enhances Paclitaxel’s Tumor-suppressing Effects in Animal Models

Raising NAD+ levels with nicotinamide riboside has been shown, in animal models, to reduce pain resulting from the cancer treating drug therapy paclitaxel. When administered to rodents in combinati...

Read more